Since the cells also exhibit low and intermediate expression of CD4 and TCRδγ, respectively, we could not completely rule out a T-cell lymphoma with aberrant expression of CD11c [52, 53], although subsequent genomic results further supported HS. Here, ITGAX is linked to T-cell non-Hodgkin lymphoma.